Viral evasion of IFN function by decoy receptor sequestration

$339,491U54FY2010AINIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 35873156 Paper 31990686 Paper 31092684 Paper 30593637 Paper 29555731 Paper 29063667 Paper 28874468 Paper 28550119 Paper 28110145 Paper 27779193 Paper 27468281 Paper 27274048 Paper 27226371 Paper 27122575 Paper 26787880 Paper 26730950 Paper 26671708 Paper 26655238 Paper 26479788 Paper 26157117 Paper 26132196 Paper 26010977 Paper 26010249 Paper 25999917 Paper 25975198 Paper 25764399 Paper 25757571 Paper 25756647 Paper 25619688 Paper 25561542 Paper 25520507 Paper 25437230 Paper 25410872 Paper 25295729 Paper 25266349 Paper 25262473 Paper 25200953 Paper 25136083 Paper 25078919 Paper 24983375 Paper 24968940 Paper 24954476 Paper 24943221 Paper 24885416 Paper 24762827 Paper 24743696 Paper 24728596 Paper 24725928 Paper 24679532 Paper 24618256 Paper 24606692 Paper 24495995 Paper 24452684 Paper 24418550 Paper 24352446 Paper 24335291 Paper 24310610 Paper 24286610 Paper 24284630 Paper 24173234 Paper 24167629 Paper 24067086 Paper 24048899 Paper 24048526 Paper 24011765 Paper 24010825 Paper 24006442 Paper 23962002 Paper 23918369 Paper 23918215 Paper 23860770 Paper 23860224 Paper 23838821 Paper 23833237 Paper 23729477 Paper 23716606 Paper 23658447 Paper 23633479 Paper 23580529 Paper 23545571 Paper 23518336 Paper 23515536 Paper 23487461 Paper 23487367 Paper 23426631 Paper 23408632 Paper 23364696 Paper 23341590 Paper 23314004 Paper 23312338 Paper 23300459 Paper 23276405 Paper 23275090 Paper 23264053 Paper 23248310 Paper 23209377 Paper 23115296 Paper 23115291 Paper 23115038 Paper 23112205

Abstract

Interferon (IFN) activity is marshaled early against the initial stages of viral infection, and IFN mediated responses play an essential role in host defense by directly inhibiting viral replication and by indirectly stimulating innate and adaptive immunity. Not surprisingly, IFN mediated signaling is a favored target of viral subterfuge. In this proposal we set out to explore the biophysical and functional attributes of two virally encoded decoy receptors that selectively neutralize the biological effects of type-l and type-Ill IFNs. Ectromelia virus encodes a decoy receptor that promiscuously binds and blocks the antiviral effects of all type-l IFNs in a species independent manner, with the notable exception of murine IFN-beta. The Yaba-like disease virus encodes a related decoy receptor that capably inhibits primate type-l (alpha and beta) as well as type-Ill (lamda) IFNs. Interestingly, neither of these viral proteins shares any significant sequence similarity with the distinct receptor components used for type-l or type-Ill IFN signal transduction. Our proposed studies aim to dissect the mechanism and consequences of selective decoy receptor mediated IFN inhibition using a diverse arsenal of experimental methods. In Aim 1 of the proposal we will determine the structural basis of IFN inhibition by viral decoy receptors using x-ray crystallography and quantitative protein interaction analysis. Results from these studies will be used in concert with yeast surface display directed evolution to develop variant decoy receptors with unique cytokine binding properties. In Aim 2 we will examine the cellular mechanisms of IFN decoy receptor function. The secreted poxvirus proteins tightly associate with cell surfaces through an unknown receptor interaction we propose to identify and investigate. We will also examine whether additional viruses encode IFN decoys. In Aim 3 we will explore the role of IFN sequestration in the mousepox pathogenesis model. Ectromelia recombinants will be generated that encode novel decoy receptors that selectively inhibit the actions of IFN-alpha, IFN-beta, or IFN-lambda at sites of viral infection in order to better understand the specific roles of these cytokines in anti-viral immunity.

View original record on NIH RePORTER →